Compile Data Set for Download or QSAR
Report error Found 1272 for UniProtKB: Q13490
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495451(CHEMBL3108827)
Affinity DataEC50:  0.100nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495462(CHEMBL3108931)
Affinity DataEC50:  0.100nMAssay Description:Induction of cIAP1 (unknown origin) degradationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2021
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495457(CHEMBL3108819)
Affinity DataEC50:  0.100nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495465(CHEMBL3108817)
Affinity DataEC50:  0.100nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450049(CHEMBL4166057)
Affinity DataIC50: 0.100nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450044(CHEMBL4167141)
Affinity DataIC50: 0.130nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450038(CHEMBL4171490)
Affinity DataIC50: 0.170nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450047(CHEMBL4169478)
Affinity DataIC50: 0.180nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450043(CHEMBL4166607)
Affinity DataIC50: 0.190nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450037(CHEMBL4164271)
Affinity DataIC50: 0.200nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495458(CHEMBL3108818)
Affinity DataEC50:  0.200nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495464(CHEMBL3108927)
Affinity DataEC50:  0.200nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495460(CHEMBL3108920)
Affinity DataEC50:  0.200nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495463(CHEMBL3108821)
Affinity DataEC50:  0.200nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450046(CHEMBL4173974)
Affinity DataIC50: 0.220nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450046(CHEMBL4173974)
Affinity DataIC50: 0.220nMAssay Description:Inhibition of cIAP1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495443(CHEMBL3108922)
Affinity DataEC50:  0.300nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
LigandPNGBDBM312982(US9605022, Example 15)
Affinity DataIC50: 0.300nMAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of His-BIR2-3 (125-356, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239422(CHEMBL234346)
Affinity DataIC50: 0.320nMAssay Description:Inhibition of SMAC-derived peptide abuRPFK (5 and 6FAM)-amide interaction with cIAP1 BIR3 domain (unknown origin) by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/22/2019
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239425(CHEMBL4064619)
Affinity DataEC50:  0.320nMAssay Description:Induction of cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/22/2019
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50239425(CHEMBL4064619)
Affinity DataIC50: 0.320nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450039(CHEMBL4160872)
Affinity DataIC50: 0.340nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50255183((1S,3S,6S,10aS)-1-benzyl-6-((S)-2-(methylamino)pro...)
Affinity DataKi:  0.370nMAssay Description:Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polari...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50441356(CHEMBL2431768)
Affinity DataIC50: 0.400nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495462(CHEMBL3108931)
Affinity DataEC50:  0.400nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
LigandPNGBDBM312990(US9605022, Example 19)
Affinity DataIC50: 0.400nMAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of His-BIR2-3 (125-356, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50393632(CHEMBL2158601)
Affinity DataKi:  0.400nMAssay Description:Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50441356(CHEMBL2431768)
Affinity DataEC50:  0.400nMAssay Description:Induction of cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/22/2019
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50343522((S,3S,3'S,6S,6'S,10aS,10a'S)-N,N'-((1S,1'S)-(1,1'-...)
Affinity DataKi:  0.5nMAssay Description:Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495453(CHEMBL3108919)
Affinity DataEC50:  0.5nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450054(CHEMBL4159232)
Affinity DataIC50: 0.590nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495466(CHEMBL3108929)
Affinity DataEC50:  0.600nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495459(CHEMBL3108921)
Affinity DataEC50:  0.600nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50495456(CHEMBL3108820)
Affinity DataEC50:  0.600nMAssay Description:Binding affinity to cIAP1 in human MDA-MB-231 cells assessed as induction of protein degradation after 1 hr by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450042(CHEMBL4168197)
Affinity DataIC50: 0.620nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM26223((3S,6S,10aS)-6-[(2S)-2-(methylamino)propanamido]-5...)
Affinity DataKi:  0.680nMAssay Description:Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polari...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50393508(CHEMBL2158054)
Affinity DataKd:  0.700nMAssay Description:Binding affinity to human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) assessed as dissociation constant after 2 to 3 hrs by fluorescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50393631(CHEMBL2158600)
Affinity DataKi:  0.700nMAssay Description:Binding affinity to BIR3 domain of cIAP1 by fluorescence polarization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine

US Patent
LigandPNGBDBM710513(US20250002493, Embodiment 25 | US20250002493, Comp...)
Affinity DataKi:  0.700nMAssay Description:The binding affinity of the compounds provided by the present invention to IAP proteins was determined using a fluorescence polarization method (Niko...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
Go to US Patent

TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450048(CHEMBL4177336)
Affinity DataIC50: 0.700nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50450051(CHEMBL4174922)
Affinity DataIC50: 0.740nMAssay Description:Induction of intracellular cIAP1 degradation in human MDA-MB-231 cells after 2 hrsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2020
Entry Details Article
PubMed
TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine

US Patent
LigandPNGBDBM710516(US20250002493, Embodiment 36 | US20250002493, Comp...)
Affinity DataKi:  0.800nMAssay Description:The binding affinity of the compounds provided by the present invention to IAP proteins was determined using a fluorescence polarization method (Niko...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
Go to US Patent

LigandPNGBDBM312988(US9605022, Example 17)
Affinity DataIC50: 0.800nMAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of His-BIR2-3 (125-356, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBaculoviral IAP repeat-containing protein 2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM26218((3S,6S,10aS)-N-(diphenylmethyl)-6-[(2S)-2-(methyla...)
Affinity DataKi:  0.800nMAssay Description:Displacement of fluorescent SM5F peptide from His-tagged human cIAP1 BIR3 domain expressed in Escherichia coli BL21(DE3) cells by fluorescence polari...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
LigandPNGBDBM312968(US9605022, Example 3)
Affinity DataIC50: 0.800nMAssay Description:Assays were performed in black, flat-bottom, 384-well plates. The final assay volume was 50 μL prepared from additions of His-BIR2-3 (125-356, C...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBaculoviral IAP repeat-containing protein 2 [254-364](Human)
Nanjing China-Australia Institute of Translational Medicine

US Patent
LigandPNGBDBM710529(US20250002493, Embodiment 55 | US20250002493, Comp...)
Affinity DataKi:  0.800nMAssay Description:The binding affinity of the compounds provided by the present invention to IAP proteins was determined using a fluorescence polarization method (Niko...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/15/2025
Entry Details
Go to US Patent

TargetBaculoviral IAP repeat-containing protein 2 [256-363](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM254000(US9481673, (S)-10)
Affinity DataIC50: 1nMT: 2°CAssay Description:BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for on...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2017
Entry Details
Go to US Patent

TargetBaculoviral IAP repeat-containing protein 2 [256-363](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM254001(US9481673, (S)-11)
Affinity DataIC50: 1nMT: 2°CAssay Description:BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for on...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2017
Entry Details
Go to US Patent

TargetBaculoviral IAP repeat-containing protein 2 [256-363](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM253998(US9481673, (S)-8)
Affinity DataIC50: 1nMT: 2°CAssay Description:BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for on...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2017
Entry Details
Go to US Patent

TargetBaculoviral IAP repeat-containing protein 2 [256-363](Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM253999(US9481673, (S)-9)
Affinity DataIC50: 1nMT: 2°CAssay Description:BIR3 domains (10 nM) were incubated with SMAC peptide (10 nM) in assay buffer (50 mM Tris, 120 mM NaCl, 0.1% BSA, 1 mM DTT, 0.05% Triton X100) for on...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/9/2017
Entry Details
Go to US Patent

Displayed 1 to 50 (of 1272 total ) | Next | Last >>
Jump to: